Five Prime Thera
(FPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | |
| Cash Flows From Operating Activities | |
| Net Income | -13,461 |
| Depreciation Amortization | 1,784 |
| Accounts payable and accrued liabilities | 1,264 |
| Other Working Capital | 2,790 |
| Other Operating Activity | -201 |
| Operating Cash Flow | $-7,824 |
| Cash Flows From Investing Activities | |
| Change In Deposits | 6,613 |
| PPE Investments | -3,313 |
| Other Investing Activity | 576 |
| Investing Cash Flow | $3,876 |
| Cash Flows From Financing Activities | |
| Debt Repayment | -6 |
| Common Stock Issued | 111 |
| Other Financing Activity | 4,459 |
| Financing Cash Flow | $4,564 |
| Beginning Cash Position | 7,437 |
| End Cash Position | 8,053 |
| Net Cash Flow | $616 |
| Free Cash Flow | |
| Operating Cash Flow | -7,824 |
| Capital Expenditure | -3,319 |
| Free Cash Flow | -11,143 |